Summary
Summary of patient status, vital signs, lab results, and treatment progression over two days.
Clinical Progress Report: July 29-30
Highlights
Clinical Assessment and Observations
On July 29, the patient remained confused with a GCS of 13/15 and exhibited persistent speech difficulties, including word omission. By July 30, the patient continued to be nursed in a cot bed, maintaining 97% oxygen saturation on room air while continuing IV Meropenem treatment.
Laboratory Results and Medical Monitoring
Blood tests on July 30 indicated several abnormal levels, specifically elevated Urea, Creatinine, SGT, and inorganic phosphate, alongside low Hemoglobin and Sodium. Cardiac monitoring remains in place as the patient enters day 9 of IV Meropenem therapy.